Up to 1 in 50 BC Residents are facing health inequities. Have Your Say with the BC Ministry of Health

The Reality

Spondyloarthritis (SpA) is a group of chronic, inflammatory diseases including axial spondyloarthritis (axSpA/AS), psoriatic arthritis (PsA), enteropathic arthritis, uveitis, and related conditions.

It is not rare. It is not mild. And it is not being adequately treated.

What you need to know:

Up to 1 in 50 people live with spondyloarthritis
SpA often begins in the teen years or early adulthood
People live with this disease for decades—often their entire lives
It impacts not just joints, but also the eyes, skin, and digestive system
It causes severe …

The Reality

Spondyloarthritis (SpA) is a group of chronic, inflammatory diseases including axial spondyloarthritis (axSpA/AS), psoriatic arthritis (PsA), enteropathic arthritis, uveitis, and related conditions.

It is not rare. It is not mild. And it is not being adequately treated.

What you need to know:

Up to 1 in 50 people live with spondyloarthritis
SpA often begins in the teen years or early adulthood
People live with this disease for decades—often their entire lives
It impacts not just joints, but also the eyes, skin, and digestive system
It causes severe pain, inflammation, and progressive damage
It takes an unacceptable 10+ years to receive a diagnosis
It is degenerative and progressive in nature

Most alarming:
Up to 50% of patients lose response to their treatment within five years. This means they must change their medication multiple times throughout their lives.

+

Speak directly to decision-makers.

Our Call to Action

We are calling on the Government of British Columbia to:

Expand access to approved and emerging treatments for spondyloarthritis
Ensure patients can transition to alternative therapies when current treatments fail
Reduce barriers and delays in treatment approval processes
Align access with clinical evidence and real-world patient need
Address interprovincial disparities and ensure equitable coverage across Canada

Send an email directly to decison-makers

In less than 30 seconds, you can help drive meaningful change.

Use the email form below and help ensure equitable access to treatment for people living with spondyloarthritis in British Columbia.

Where do you live?

Compose your email

Name

Email

Subject:

I am writing as a constituent to urge action on improving access to care for people living with spondyloarthritis (SpA) in British Columbia.

SpA is a chronic, inflammatory disease that causes significant pain, disability, and long-term health impacts. Yet in BC, patients face limited and inconsistent access to treatments. With up to 50% of patients losing response to therapy within five years, access to multiple treatment options over time is essential.

Current barriers and delays mean many people are left without options, leading to worsening disease and reduced quality of life. BC is falling behind other provinces in providing equitable access to care.

I am asking the Government of British Columbia to:
- Expand access to approved and emerging treatments
- Reduce barriers and delays in treatment approvals
- Ensure patients can switch therapies when needed
- Align coverage with clinical evidence and patient need

Thank you for your attention to this urgent issue. I hope you will take action to improve care for people living with SpA in BC.

How we use the data you enter on this form

Do Gooder (the advocacy platform powering this online action) processes personal information from you that you enter on this form so that we can provide the functions and related services to you and The Campaigner (the organisation responsible for this online action) for their legitimate purposes, including possibly exporting it to other systems, and to effectively respond to enquiries and communications related to those services.

Specifically when you enter:

Your location data (residential address or postcode) it is used to locate your elected representative, to pre-populate your email signature and to provide The Campaigner with a visualisation of the location of the support for this campaign.
All other data you may enter, including your email address, name, telephone number, commentary and so on is used by The Campaigner to advocate for the campaign’s goals and where required may be sent to the target of the campaign.

The data collected by Do Gooder is also used by us in aggregate form to improve the service and may be held on your behalf outside your country of residence by our third party service providers. These providers are bound by contract to only use personal information on our behalf, in accordance with agreed terms. While the privacy laws of the country in which personal information is stored or transferred may be different from those in your country, we will always have safeguards in place when storing or transferring personal information. We will never sell, rent, loan or in any other way pass your information on to other parties other than to provide this service to you and The Campaigner.

The personal information collected by Do Gooder is held subject to a Data Processing Agreement between Do Gooder and The Campaigner in compliance with the EU's GDPR and Australian law.

Learn more about our privacy policy here

How is my data used?